Encompass Health Corporation

84.93+2.27+2.75%Vol 956.68K1Y Perf 21.23%
Apr 16th, 2021 16:00 DELAYED
BID76.25 ASK85.81
Open83.15 Previous Close82.66
Pre-Market- After-Market-
 - -  - -%
Target Price
93.75 
Analyst Rating
Strong Buy 1.54
Potential %
10.39 
Finscreener Ranking
★★★     49.57
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★★     47.03
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★★★     59.99
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
★+     39.07
Market Cap8.43B 
Earnings Rating
Sell
Price Range Ratio 52W %
88.14 
Earnings Date
27th Apr 2021

Today's Price Range

83.1585.60

52W Range

58.9988.42

5 Year PE Ratio Range

13.3029.10

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
4.03%
1 Month
6.50%
3 Months
1.81%
6 Months
24.79%
1 Year
21.23%
3 Years
46.70%
5 Years
145.37%
10 Years
292.14%

TickerPriceChg.Chg.%
EHC84.932.27002.75
AAPL134.16-0.3400-0.25
GOOG2 297.761.10000.05
MSFT260.741.24000.48
XOM56.66-0.3200-0.56
WFC43.841.60003.79
JNJ162.241.85001.15
FB306.18-1.6400-0.53
GE13.39-0.1600-1.18
JPM153.301.13000.74
Financial StrengthValueIndustryS&P 500US Markets
1.10
1.30
0.69
2.23
3.60
Leverage Ratio 4.30
ProfitabilityValueIndustryS&P 500US Markets
95.60
14.10
19.40
12.40
7.45
RevenueValueIndustryS&P 500US Markets
3.46B
34.88
5.31
7.49
DividendsValueIndustryS&P 500US Markets
1.38
1.12
14.40
10.55
Payout ratio41.00
Earnings HistoryEstimateReportedSurprise %
Q04 20200.860.938.14
Q03 20200.750.784.00
Q02 20200.390.31-20.51
Q01 20200.870.870.00
Q04 20190.870.85-2.30
Q03 20190.890.934.49
Q02 20190.971.0811.34
Q01 20190.891.0416.85
Earnings Per EndEstimateRevision %Trend
3/2021 QR0.80-8.05Negative
6/2021 QR0.82-7.87Negative
12/2021 FY3.46-9.42Negative
12/2022 FY4.03-2.89Negative
Next Report Date27th Apr 2021
Estimated EPS Next Report0.80
Estimates Count6
EPS Growth Next 5 Years %15.60
Volume Overview
Volume956.68K
Shares Outstanding99.27M
Trades Count12.55K
Dollar Volume70.33M
Avg. Volume642.21K
Avg. Weekly Volume428.75K
Avg. Monthly Volume606.79K
Avg. Quarterly Volume659.46K

Encompass Health Corporation (NYSE: EHC) stock closed at 84.93 per share at the end of the most recent trading day (a 2.75% change compared to the prior day closing price) with a volume of 956.74K shares and market capitalization of 8.43B. Is a component of Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 43178 people. Encompass Health Corporation CEO is Mark J. Tarr.

The one-year performance of Encompass Health Corporation stock is 21.23%, while year-to-date (YTD) performance is 2.71%. EHC stock has a five-year performance of 145.37%. Its 52-week range is between 58.99 and 88.42, which gives EHC stock a 52-week price range ratio of 88.14%

Encompass Health Corporation currently has a PE ratio of 28.70, a price-to-book (PB) ratio of 5.12, a price-to-sale (PS) ratio of 2.33, a price to cashflow ratio of 11.60, a PEG ratio of 2.32, a ROA of 4.33%, a ROC of 7.84% and a ROE of 18.51%. The company’s profit margin is 7.45%, its EBITDA margin is 19.40%, and its revenue ttm is $3.46 Billion , which makes it $34.88 revenue per share.

Of the last four earnings reports from Encompass Health Corporation, there were 2 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $0.80 for the next earnings report. Encompass Health Corporation’s next earnings report date is 27th Apr 2021.

The consensus rating of Wall Street analysts for Encompass Health Corporation is Strong Buy (1.54), with a target price of $93.75, which is +10.39% compared to the current price. The earnings rating for Encompass Health Corporation stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Encompass Health Corporation has a dividend yield of 1.38% with a dividend per share of $1.12 and a payout ratio of 41.00%.

Encompass Health Corporation has a Buy technical analysis rating based on Technical Indicators (ADX : 6.60, ATR14 : 2.21, CCI20 : 230.41, Chaikin Money Flow : 0.04, MACD : 0.17, Money Flow Index : 40.82, ROC : 2.57, RSI : 63.04, STOCH (14,3) : 88.81, STOCH RSI : 1.00, UO : 52.86, Williams %R : -11.19), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Encompass Health Corporation in the last 12-months were: Andrew Price (Sold 8 589 shares of value $699 145 ), Barbara Jacobsmeyer (Sold 2 500 shares of value $161 825 ), Douglas E. Coltharp (Option Excercise at a value of $568 959), Douglas E. Coltharp (Sold 23 501 shares of value $1 779 937 ), Elissa Joy Charbonneau (Sold 6 650 shares of value $500 213 ), Mark J. Tarr (Option Excercise at a value of $549 295), Mark J. Tarr (Sold 26 132 shares of value $1 618 093 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
10 (76.92 %)
11 (78.57 %)
11 (78.57 %)
Moderate Buy
1 (7.69 %)
1 (7.14 %)
1 (7.14 %)
Hold
1 (7.69 %)
1 (7.14 %)
1 (7.14 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
1 (7.69 %)
1 (7.14 %)
1 (7.14 %)
Summary RatingStrong Buy
1.54
Strong Buy
1.50
Strong Buy
1.50

Encompass Health Corporation

Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. It operates in two segments: inpatient rehabilitation and home health and hospice. The Inpatient rehabilitation segment contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. These hospitals are concentrated in the eastern half of the United States and Texas. The Home health and hospital segment provides skilled home health services through agencies concentrated in the southeastern United States and Texas, which include nursing, physical, occupational, and speech therapy, social work, and hospice services.

CEO: Mark J. Tarr

Telephone: +1 205 967-7116

Address: 9001 Liberty Parkway, Birmingham 35242, AL, US

Number of employees: 43 178

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

53%47%

Bearish Bullish

50%50%

Bearish Bullish

49%51%

News

Stocktwits